The penile erection efficacy of a new phosphodiesterase type 5 inhibitor, mirodenafil (SK3530), in rabbits with acute spinal cord injury

Journal of Veterinary Medical Science

Volumn 70, Issue 11, 2008, Pages 1199-1204

  Jung, Ji Youn ^a   Kim, Sang Ki ^a   Kim, Byeong Soo ^a   Lee, Seung Ho ^a   Park, Young Seok ^a   Kim, So Jung ^a   Choi, Changsun ^b   Yoon, Seong Il ^c   Kim, Jong Suk ^d   Cho, Sung Dae ^e   Im, Gwang Jin ^f   Lee, Soo Min ^f   Jung, Ji Won ^g   Lee, Yong Soon ^g  

^a Kongju National University   (South Korea)

^b Chung Ang University   (South Korea)

^c Hanyang University   (South Korea)

^d Chungbuk National University   (South Korea)

^e Chonbuk National University   (South Korea)

^f SK Chemicals   (South Korea)

^g Seoul National University   (South Korea)

Author keywords

Mirodenafil; Penile erection; Phosphodiesterase inhibitor; SK3530; Spinal cord injury

Indexed keywords

MIRODENAFIL; PHOSPHODIESTERASE V; PYRIMIDINONE DERIVATIVE; SULFONAMIDE;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; ERECTILE DYSFUNCTION; MALE; MUCOSA; ORAL DRUG ADMINISTRATION; PENIS ERECTION; RABBIT; SPINAL CORD INJURY;

ADMINISTRATION, ORAL; ANIMALS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; ERECTILE DYSFUNCTION; MALE; MUCOUS MEMBRANE; PENILE ERECTION; PYRIMIDINONES; RABBITS; SPINAL CORD INJURIES; SULFONAMIDES;

ORYCTOLAGUS CUNICULUS;

EID: 57349158623     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.70.1199     Document Type: Article

References (32)

1. Agee, J. M., Flanagan, T., Blackbourne, L. H., Kron, I. L. and Tribble, C. G. 1991. Reducing postischemic paraplegia using conjugated superoxide dismutase. Ann. Thorac. Surg. 51: 911-914.
2. Aloni, R., Heller, L., Keren, O., Mendelson, E. and Davidoff, G. 1992. Noninvasive treatment for erectile dysfunction in the neurogenically disabled population. J. Sex. Marital. Ther. 18: 243-249.
3. Andersson, K. E. and Wagner, G. 1995. Physiology of penile erection. Physiol. Rev. 75: 191-236.
4. Andersson, K. E. 2001. Neurophysiology/pharmacology of erection. Int. J. Impot. Res. 13: S8-S17.
5. Aydin, S., Ozbek, H., Yilmaz, Y., Atilla, M. K., Bayrakli, H. and Cetin, H. 2001. Effects of sildenafil citrate, acetylcholine, and sodium nitroprusside on the relaxation of rabbit cavernosal tissue in vitro. Urology 58: 119-124.
6. Aytac, I. A., Araujo, A. B., Johannes, C. B., Kleinman, K. P. and McKinlay, J. B. 2000. Socioeconomic factors and incidence of erectile dysfunction: findings of the longitudinal Massachussetts Male Aging Study. Soc. Sci. Med. 51: 771-778.
7. Bodner, D. R., Haas, C. A., Krueger, B. and Seftel, A. D. 1999. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury. Urology 53: 199-202.
8. Brown, J. H. and Taylor, P. 1995. Muscarinic receptor agonists and antagonist. pp. 141-160. In: Goodman and Gilman's the Pharmacological Basis of Therapeutics (Hardman, J.C. ed.), McGraw-Hill professional, New York.
9. Cassada, D. C., Gangemi, J. J., Rieger, J. M., Linden, J., Kaza, A.K., Long, S. M., Kron, I. L., Tribble, C. G. and Kern, J. A. 2001. Systemic adenosine A2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord. Ann. Thorac. Surg. 72: 1245-1250.
10. De Tejada, I. S. 2004. Therapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat. Int. J. Impot. Res. 16: 40-42.
11. Greco, B., Edwards, D. A., Zumpe, D., Michael, R. P. and Clancy, A. N. 1998. Fos induced by mating or noncontact sociosexual interaction is colocalized with androgen receptors in neurons within the forebrain, midbrain, and lumbosacral spinal cord of male rats. Horm. Behav. 33: 125-138.
12. Greiner, K. A. and Weigel, J. W. 1996. Erectile dysfunction. Am. Fam. Physician 54: 1675-1682.
13. Hancock, M. B. and Peveto, C. A. 1979. Preganglionic neurons in the sacral spinal cord of the rat: an HRP study. Neurosci. Lett. 11: 1-5.
14. Junemann, K. P., Buhrle, C. P. and Persson-Junemann, C. 1994. Pathophysiology of neurogenic impotence. Sex. Disabil. 12: 5-15.
15. Kalsi, J. S., Ralph, D. J., Thomas, P., Bellringer, J., Minhas, S., Kell, P. D. and Cellek, S. 2005. A nitric oxide-releasing PDE5 inhibitor relaxes human corpus cavernosum in the absence of endogenous nitric oxide. J. Sex Med. 2: 53-57.
16. Kang, K. K., Ahn, G. J., Ahn, B. O., Yoo, M. and Kim, W. B. 2003. DA-8159, a new PDE5 Inhibitor, induces penile erection in conscious and acute spinal cord injured rabbits. Eur. Urol. 43: 689-695.
17. Lincoln, T. M. 2004. Cyclic GMP and phosphodiesterase 5 inhibitor therapies: what's on the horizon? Mol. Pharmacol. 66: 11-13.
18. Marson, L. and McKenna, K. E. 1996. CNS cell groups involved in the control of the ischiocavernosus and bulbospongiosus muscles: a transneuronal tracing study using pseudorabies virus. J. Comp. Neurol. 374: 161-179.
19. Nadelhaft, I. and Booth, A. M. 1984. The location and morphology of preganglionic neurons and the distribution of visceral afferents from the rat pelvic nerve: a horseradish peroxidase study. J. Comp. Neurol. 226: 238-245.
20. Oh, J. G., Jang, W. J. and Chi, S. C. 2007. Validation of a HPLC method for the quantification and purity determination of SK3530 in drug substance and tablet. J. Pharm. Biomed. Anal. 43: 1179-1184.
21. Okita, Y., Takamoto, S., Ando, M., Morota, T., Yamaki, F., Matsukawa, R. and Kawashima, Y. 1997. Repair for aneurysms of the entire descending thoracic aorta or thoracoabdominal aorta using a deep hypothermia. Eur. J. Cardiothorac. Surg. 12: 120-126.
22. Parrino, P. E., Kron, I. L., Ross, S. D., Shockey, K. S., Fisher, M. J., Gaughen, JR Jr., Kern, J. A. and Tribble, C. G. 1999. Spinal cord protection during aortic cross-clamping using retrograde venous perfusion. Ann. Thorac. Surg. 67: 1589-1594.
23. Rampin, O., Gougis, S., Giuliano, F. and Rousseau, J.P. 1997. Spinal Fos labeling and penile erection elicited by stimulation of dorsal nerve of the rat penis. Am. J. Physiol. 272: 1425-1431.
24. Selvin, E., Burnett, A. L. and Platz, E. A. 2007. Prevalence and risk factors for erectile dysfunction in the US. Am. J. Med. 120: 151-157.
25. Shin, B. S., Hu, S. K., Kim, J., Oh, J. G., Youn, W. N., Lee, B., Um, K. A., Kim, D. K., Lee, J. Y. and Yoo, S. D. 2007. Development of LC/MS/MS assay for the determination of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazine-1-sulfonyl]- 2-propoxyphenyl}-7-propyl-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one (SK3530) in human plasma: application to a clinical pharmacokinetic study. J. Pharm. Biomed. Anal. 45: 176-184.
26. 14C-SK3530·2HCl). J. Label. Compd. Radiopharm. 49: 1141-1149.
27. Tetik, O., Islamoglu, F., Yagdi, T., Atay, Y., Calkavur, T., Ozbek, C., Canpolat, L., Buket, S. and Vuksel, M. 2001. An intraaortic solution trial to prevent spinal cord injury in a rabbit model. Eur. J. Vasc. Endovasc. Surg. 22: 175-179.
28. Traish, A. and Kim, N. 2005. The physiological role of androgens in penile erection: regulation of corpus cavernosum structure and function. J. Sex Med. 2: 759-770.
29. Uckert, S., Kuthe, A., Stief, C. G. and Jonas, U. 2001. Phosphodiesterase isoenzymes as pharmacological targets in the treatment of male erectile dysfunction. World J. Urol. 19: 14-22.
30. Van Niekerk, J. L., Heijstraten, F. M., Goris, R. J., Buskens, F. G., Eijgelaar, A. and Lacquet, L. K. 1986. Spinal cord injury following surgery for acute traumatic rupture of the thoracic aorta. Thorac. Cardiovasc. Surg. 34: 30-34.
31. Vardi, Y. and Siroky, M. B. 1990. Hemodynamics of pelvic nerve induced erection in a canine model. I. Pressure and flow. J. Urol. 144: 794-797.
32. Yoo, H. H., Kim, N. S., Im, G. J. and Kim, D. H. 2007. Pharmacokinetics and tissue distribution of a novel PDE5 inhibitor, SK-3530, in rats. Acta Pharmacol. Sin. 28: 1247-1253.